Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients

Vallin, Mélanie; Guillaud, Olivier; Morard, Isabelle; Gagnieu, Marie-Claude; Mentha, Gilles; Adham, Mustapha; Morelon, Emmanuel; Boillot, Olivier; Giostra, Emiliano; Dumortier, Jérôme

doi:10.1111/j.1399-0012.2010.01370.x

Advanced search

Browse by...

Deposit

Highlights

More informations

Title		Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients
Authors		Vallin, Mélanie Guillaud, Olivier Morard, Isabelle Gagnieu, Marie-Claude Mentha, Gilles Adham, Mustapha Morelon, Emmanuel Boillot, Olivier Giostra, Emiliano Dumortier, Jérôme show all authors [1 - 10]
Published in		Clinical Transplantation. 2011, vol. 25, no. 4, p. 660-9
Abstract		The aim of this study was to evaluate the tolerability of the conversion from calcineurin inhibitor (CNI) to everolimus (ERL) in maintenance liver transplant (LT) recipients.
Keywords		Calcineurin/antagonists & inhibitors — Cohort Studies — Cyclosporine/therapeutic use — Female — Follow-Up Studies — Graft Rejection/drug therapy — Graft Survival — Humans — Immune Tolerance/drug effects — Immunosuppressive Agents/therapeutic use — Liver Transplantation — Male — Middle Aged — Sirolimus/analogs & derivatives/therapeutic use — Survival Rate — Tacrolimus/therapeutic use — Treatment Outcome
Identifiers		DOI: 10.1111/j.1399-0012.2010.01370.x PMID: 21158921
Full text		Article (Published version) (181 Kb) - Limited access to UNIGE
Structures		Faculté de médecine / Section de médecine clinique / Département de médecine Faculté de médecine / Section de médecine clinique / Département de chirurgie
Research group		Hépatologie chirurgicale (327)
Citation (ISO format)		VALLIN, Mélanie et al. Tolerability of everolimus-based immunosuppression in maintenance liver transplant recipients. In: Clinical Transplantation, 2011, vol. 25, n° 4, p. 660-9. doi: 10.1111/j.1399-0012.2010.01370.x https://archive-ouverte.unige.ch/unige:25232